Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Bristol-Myers Squibb describes new taxanes

Aug. 19, 1997

VEGF RTK inhibitors in the pipeline at Zeneca

Aug. 18, 1997

Terrapin and Taiho sign development agreement for anticancer agent

Aug. 18, 1997

Xechem granted patent for paclitaxel isolation and purification method

Aug. 14, 1997

Paclitaxel combination therapy in lung cancer

Aug. 14, 1997

Taxotere cleared in four additional countries

Aug. 13, 1997

MMP inhibitors described by Agouron

Aug. 13, 1997

EntreMed and the National Cancer Institute sign letters of intent

Aug. 12, 1997

Oncormed allowed U.S. patent for BRCA1 gene

Aug. 11, 1997

Bristol-Myers Squibb acquires broad-spectrum antitumor agents

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...